Bristol Myers Squibb CELG-RI
NYSE CELG-RI
$0.11 0.00 (-1.19%)
As of: Sep 10, 2026 · 11:55 AM EDT

Bristol Myers Squibb (CELG-RI) Work In Process (2010 - 2013)

Bristol Myers Squibb's (CELG-RI) quarterly Work In Process came in at $884.0 million in Q1 2013, up 22.61% year-over-year from $721.0 million in Q1 2012, and up 8.6% quarter-over-quarter from $814.0 million in Q4 2012.

Analysis

Bristol Myers Squibb (CELG-RI) Work In Process (2010 - 2013) Analysis & Trends

Bristol Myers Squibb (CELG-RI) has reported Work In Process for 4 consecutive years, with $884.0 million the latest figure, recorded in Q1 2013.

  • On a quarterly basis, Work In Process rose 22.61% year-over-year to $884.0 million in Q1 2013; TTM through Mar 2013 was $884.0 million, a 22.61% increase from a year earlier, with the FY2012 full-year figure at $814.0 million, up 26.01% from the prior year.
  • Work In Process was $884.0 million for Q1 2013 at Bristol Myers Squibb, up from $814.0 million in the prior quarter.
  • Over five years, Work In Process peaked at $884.0 million in Q1 2013 and troughed at $608.0 million in Q4 2010.
  • A 4-year average of $739.3 million and a median of $715.0 million in 2011 frame the typical range for Work In Process.
  • The widest YoY moves for Work In Process: up 26.01% in 2012, down 4.49% in 2012.
  • Over 4 years, Work In Process stood at $608.0 million in 2010, then rose by 6.25% to $646.0 million in 2011, then advanced by 26.01% to $814.0 million in 2012, then gained by 8.6% to $884.0 million in 2013.
  • The last three Work In Process figures came in at $884.0 million (Q1 2013), $814.0 million (Q4 2012), and $868.0 million (Q3 2012), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 642.46 Bn 621.70 Bn 17.26 Bn
2 AbbVie 447.01 Bn 440.44 Bn 12.70 Bn
3 Merck 358.21 Bn 351.07 Bn 12.21 Bn
4 Novartis Ag 267.54 Bn 259.85 Bn 11.24 Bn
5 Pfizer 156.67 Bn 144.97 Bn 10.94 Bn
6 Sanofi 52.23 Bn 44.85 Bn 10.79 Bn
7 Revolution Medicines 42.86 Bn 42.86 Bn -
8 Incyte 24.60 Bn 20.06 Bn 1.57 Bn
9 United Therapeutics 21.31 Bn 18.64 Bn 683.80 Mn
10 Bristol Myers Squibb 232.18 Mn -10.83 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 884.00 Mn
Dec 31, 2012 814.00 Mn
Sep 30, 2012 868.00 Mn
Jun 30, 2012 755.00 Mn
Mar 31, 2012 721.00 Mn
Dec 31, 2011 646.00 Mn
Sep 30, 2011 709.00 Mn
Jun 30, 2011 698.00 Mn
Mar 31, 2011 690.00 Mn
Dec 31, 2010 608.00 Mn